A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

Overview of attention for article published in Molecular Imaging and Biology, October 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5 followers.

A Phase 2 Study of 16Î±-[(18)F]-fluoro-17Î²-estradiol Positron Emission Tomography (FES-PET) as a Marker of... http://t.co/w8e6uepEAl

Reply Repost Favourite